(MENAFN- GlobeNewsWire - Nasdaq) Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic ...

New York, USA, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Chronic Pain Clinical Trial Pipeline Experiences Momentum ... Centrexion Therapeutics, Neumentum Inc., Grünenthal, Synerkine Pharma, Intra ...

Analyst Sam Slutsky of LifeSci Capital maintained a Buy rating on Immunovant (IMVT – Research Report), retaining the price target of ...

TOKYO, Jan 31 (Reuters) - Japan is considering offering support for a $44 billion gas pipeline in Alaska as it seeks to court U.S. President Donald Trump and forestall potential trade friction ...

$500 million upfront and a total deal value of up to $5 billion sounds like a deal made by a top-tier pharma company – but, in fact, it comes from diminutive biotech Summit Therapeutics.

ISELIN, N.J., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United ...

Eaton Vance Short Duration High IncomeFd earns a High Process Pillar rating. The primary contributor to the rating is its parent firm's excellent long-term risk-adjusted performance, as shown by ...

After hours: February 4 at 6:33:48 PM EST Loading Chart for CARA ...

After hours: February 3 at 6:54:22 PM EST Loading Chart for BTAI ...

After hours: February 3 at 5:17:46 PM EST Loading Chart for BCYC ...

Sanofi S.A. Part Cert 0.02% €8.03M ...